Office of Infectious Diseases

Office of Infectious Diseases
Name	Office of Infectious Diseases
Jurisdiction	United States Department of Health and Human Services
Headquarters	Washington, D.C.
Formed	20th century
Chief1 name	Director
Parent agency	Centers for Disease Control and Prevention

Contents

Office of Infectious Diseases The Office of Infectious Diseases is a component within Centers for Disease Control and Prevention focused on prevention, control, and elimination of infectious threats including viral, bacterial, fungal, and parasitic infections. It coordinates activities across federal entities such as National Institutes of Health, Food and Drug Administration, Department of Defense, and international partners like World Health Organization and Pan American Health Organization. The office engages with academic institutions including Johns Hopkins University, Harvard University, and University of Oxford to translate research into policy for agencies such as United Nations Children's Fund and European Centre for Disease Prevention and Control.

History

The office traces roots to early 20th-century public health efforts including the H1N1 influenza pandemic of 1918–1919, the establishment of Public Health Service laboratories, and responses to outbreaks like Yellow Fever Commission investigations. Later milestones include collaboration during the HIV/AIDS epidemic with Centers for Disease Control and Prevention divisions and coordination with the National Institute of Allergy and Infectious Diseases for vaccine research. The office adapted after crises such as the 2003 SARS outbreak, the 2009 swine flu pandemic, and the Ebola virus epidemic in West Africa (2014–2016), shaping policies alongside African Union health initiatives and Médecins Sans Frontières operations. Legislative and organizational shifts involved entities like Office of Management and Budget and statutes shaped by debates in the United States Congress and oversight from Government Accountability Office.

Leadership typically includes a Director reporting to senior officials in Department of Health and Human Services and coordinating with the directors of National Institutes of Health, Centers for Medicare & Medicaid Services, and the Defense Threat Reduction Agency. The office is organized into divisions mirroring disease domains seen in World Health Assembly agendas, with program managers drawn from institutions like Columbia University, University of California, San Francisco, and Emory University. Advisory input comes from panels including members from American Medical Association, Infectious Diseases Society of America, and representatives from Bill & Melinda Gates Foundation. Recruitment and staffing intersect with professional societies such as American Society for Microbiology and accreditation bodies like Joint Commission.

Core functions encompass outbreak investigation linked to networks like Global Outbreak Alert and Response Network, immunization initiatives aligned with Global Alliance for Vaccines and Immunization, antimicrobial stewardship promoted with World Organisation for Animal Health, and laboratory capacity building in partnership with Pasteur Institute and Wellcome Trust. Programs address vaccine-preventable diseases prioritized by Advisory Committee on Immunization Practices, vector control efforts informed by Centers for Disease Control and Prevention entomology units, and antimicrobial resistance strategies consistent with National Action Plan for Combating Antibiotic-Resistant Bacteria. The office administers grant programs working with universities such as Stanford University and Massachusetts Institute of Technology and supports training pipelines with Johns Hopkins Bloomberg School of Public Health and London School of Hygiene & Tropical Medicine.

Surveillance systems integrate data from networks such as FluNet, Global Influenza Surveillance and Response System, and genomic platforms related to Nextstrain and projects at Broad Institute. Research priorities often align with grants from National Science Foundation, cooperative agreements with Centers for Disease Control and Prevention, and partnerships with Moderna, Inc. and Pfizer in vaccine trials overseen by Institutional Review Board processes. The office collaborates on pathogen genomics with institutions like Sanger Institute and bioinformatics centers at European Bioinformatics Institute and supports cohort studies tied to Framingham Heart Study-style longitudinal models. Surveillance for zoonotic spillover involves coordination with United States Geological Survey and wildlife programs at Smithsonian Institution.

Emergency response functions coordinate with Federal Emergency Management Agency, Department of Homeland Security, and international responders such as International Federation of Red Cross and Red Crescent Societies. The office maintains incident command structures analogous to National Incident Management System and works in exercises with partners including Operation Warp Speed stakeholders and Coalition for Epidemic Preparedness Innovations. Logistics and supply chain resilience draw on lessons from collaborations with United States Agency for International Development and private sector partners like McKesson Corporation. Training and simulation exercises have been held with military medical research entities such as Walter Reed Army Institute of Research.

Partnerships span global organizations like World Health Organization, Gavi, the Vaccine Alliance, regional agencies like Africa Centres for Disease Control and Prevention, and academic consortia including Consortium of Universities for Global Health. The office engages with philanthropic organizations such as Rockefeller Foundation and Wellcome Trust, private sector firms like Johnson & Johnson and GlaxoSmithKline, and non-governmental organizations including Partners In Health and Red Cross. Collaborative research projects have included networks with European Commission research programs and data-sharing agreements with initiatives like Global Health Security Agenda. Joint training and capacity-building occur with institutions such as African Field Epidemiology Network and Asia Pacific Strategy for Emerging Diseases.